Aurinia Pharmaceuticals Inc. — Director's Dealing 2021

Sep 14, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aurinia Pharmaceuticals Inc. (AUPH)
CIK: 0001600620
Period of Report: 2021-09-10

Reporting Person: Huizinga Robert Bindert (EVP of Research)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-10	Common Stock	S	5000	$19.83	Disposed	133592	Direct
2021-09-10	Common Stock	S	5000	$19.76	Disposed	128592	Direct
2021-09-14	Common Stock	S	22500	$21.75	Disposed	106092	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.